A Rare, In-Frame BCR-ABL Fusion (e13a3) in a Patient with an Aggressive Chronic Myeloid Leukaemia

Publisher： Karger

E-ISSN： 1421-9662|108|3|150-153

ISSN： 0001-5792

Source： Acta Haematologica, Vol.108, Iss.3, 2002-09, pp. : 150-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute Lymphoblastic Leukaemia with an e1a3 BCR-ABL1 Fusion

By  

Acta Haematologica, Vol. 126, Iss. 4, 2011-09 ,pp. : 214-215

Karger

Access to resources Recommend Favorite

Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant

By  

Acta Haematologica, Vol. 120, Iss. 3, 2008-11 ,pp. : 146-149

Karger

Access to resources Recommend Favorite

International Reporting Scale of BCR-ABL1 Fusion Transcript in Chronic Myeloid Leukemia: First Report from India

By  

Acta Haematologica, Vol. 127, Iss. 3, 2012-01 ,pp. : 135-142

Karger

Access to resources Recommend Favorite

Identification of an Acute Basophilic Leukaemia Carrying a Rare e6a2 BCR-ABL Transcript

By  

Acta Haematologica, Vol. 116, Iss. 3, 2006-10 ,pp. : 216-218

Karger

Access to resources Recommend Favorite

Rapid reduction in BCR‐ABL1 transcript predicts deep molecular response in dasatinib‐treated chronic‐phase chronic myeloid leukaemia patients

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 1, 2018-01 ,pp. : 27-35

John Wiley & Sons Inc

Access to resources Recommend Favorite